Comparison of the Levels of Immunogenicity and Safety of Zostavax in Adults 50 to 59 Years Old and in Adults 60 Years Old or Older

Title
Comparison of the Levels of Immunogenicity and Safety of Zostavax in Adults 50 to 59 Years Old and in Adults 60 Years Old or Older
Authors
Keywords
-
Journal
Clinical and Vaccine Immunology
Volume 16, Issue 5, Pages 646-652
Publisher
American Society for Microbiology
Online
2009-03-05
DOI
10.1128/cvi.00407-08

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now